| GC30367-50mg |
|
1303469-70-6 |
KHK-IN-1 (ketohexokinase inhibitor)
|
0 |
C21H26N8S |
|
|
|
| GC30367-10mg |
|
1303469-70-6 |
KHK-IN-1 (ketohexokinase inhibitor)
|
0 |
C21H26N8S |
|
|
|
| GC30367-5mg |
|
1303469-70-6 |
KHK-IN-1 (ketohexokinase inhibitor)
|
0 |
C21H26N8S |
|
|
|
| GC30366-5g |
|
184475-71-6 |
|
0 |
C15H11ClFN3O2 |
|
|
|
| GC30366-1g |
|
184475-71-6 |
|
0 |
C15H11ClFN3O2 |
|
|
|
| GC30366-10mM(1mLinDMSO) |
|
184475-71-6 |
|
0 |
C15H11ClFN3O2 |
|
|
|
| GC30365-1g |
|
3520-42-1 |
Sulforhodamine B sodium salt (Acid Red 52)
|
0 |
C27H29N2NaO7S2 |
|
|
|
| GC30365-100mg |
|
3520-42-1 |
Sulforhodamine B sodium salt (Acid Red 52)
|
0 |
C27H29N2NaO7S2 |
|
|
|
| GC30365-10mM (in 1mL DMSO) |
|
3520-42-1 |
Sulforhodamine B sodium salt (Acid Red 52)
|
0 |
C27H29N2NaO7S2 |
|
|
|
| GC30364-100mg |
|
1083-57-4 |
Bucetin (3-Hydroxy-p-butyrophenetidide)
|
0 |
C12H17NO3 |
|
|
|
| GC30364-10mM(1mLinDMSO) |
|
1083-57-4 |
Bucetin (3-Hydroxy-p-butyrophenetidide)
|
0 |
C12H17NO3 |
|
|
|
| GC30363-1g |
|
4065-45-6 |
Sulisobenzone (Benzophenone-4)
|
0 |
C14H12O6S |
|
|
|
| GC30363-10mM(1mLinDMSO) |
|
4065-45-6 |
Sulisobenzone (Benzophenone-4)
|
0 |
C14H12O6S |
|
|
|
| GC30362-20mg |
|
1124198-17-9 |
|
0 |
C16H14F3N3O2S |
|
|
|
| GC30362-10mg |
|
1124198-17-9 |
|
0 |
C16H14F3N3O2S |
|
|
|
| GC30362-5mg |
|
1124198-17-9 |
|
0 |
C16H14F3N3O2S |
|
|
|
| GC30362-1mg |
|
1124198-17-9 |
|
0 |
C16H14F3N3O2S |
|
|
|
| GC30361-50mg |
|
123066-64-8 |
|
0 |
C11H7F6N3 |
|
|
|
| GC30361-10mg |
|
123066-64-8 |
|
0 |
C11H7F6N3 |
|
|
|
| GC30361-5mg |
|
123066-64-8 |
|
0 |
C11H7F6N3 |
|
|
|
